GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

Home・Elenco Azioni・BioArctic AB

B
BioArctic AB

Chiusa

290 -7.29

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

272.2

Massimo

312.8

Metriche Chiave
By Trading Economics
Entrata	-979M 97M
Vendite	-897M 392M
P/E Media del settore	25.665 35.733
EPS	1.09
Margine di Profitto	24.623
Dipendenti	119
EBITDA	1.1B 1.1B

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	6.6B 27B
Apertura precedente	297.29
Chiusura precedente	290

BioArctic AB Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 set 2025, 16:09 UTC

Acquisizioni, Fusioni, Takeovers

BBVA Clears Last Hurdle to Open $17.4 Billion Bid to Sabadell Shareholders -- 2nd Update

5 set 2025, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

5 set 2025, 20:37 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Assets of Auction Include Nationwide Retail Distribution Network of More Than 4,000 Branded Service Stations >BLUWU

5 set 2025, 20:37 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Assets of Auction Include Lubricant and Blending Plants Supporting Specialty Fuels and Lubricants >BLUWU

5 set 2025, 20:36 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Assets of Auction Include Midstream Infrastructure, Including Pipelines and Terminals Such as the Sour Lake Crude Pipeline >BLUWU

5 set 2025, 20:36 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Assets of Auction Include Refineries at Lake Charles, La., Lemont, Ill., Corpus Christi, Texas, With Combined Refining Capacity Exceeding 800,000 Barrels per Day >BLUWU

5 set 2025, 20:33 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Proposal Would Provide $3.2B Settlement for Holders of PDVSA 2020 Bonds to Be Paid Either in Cash or in Shrs of Publicly Listed Entity That Will Own Citgo >BLUWU

5 set 2025, 20:33 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Proposal Would Provide Cash or Stk Distributions to PDV Holding Inc.'s General Creditors >BLUWU

5 set 2025, 20:31 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water Acquisition Corp. III: Announces Submission of $10B Bid for PDV Holding Inc., Parent of Citgo Petroleum Corp.

5 set 2025, 20:20 UTC

Utili

These Stocks Moved the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

5 set 2025, 19:23 UTC

Discorsi di Mercato

Oil Futures Extend Losses Ahead of OPEC+ Meeting -- Market Talk

5 set 2025, 19:22 UTC

Utili

Week's Best: Insurance Costs, Like Sea Levels, Are Rising -- Barrons.com

5 set 2025, 19:17 UTC

Discorsi di Mercato

U.S. Natural Gas Snaps Winning Streak -- Market Talk

5 set 2025, 18:59 UTC

Utili

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

5 set 2025, 18:35 UTC

Discorsi di Mercato

BMO Leans Toward September Canada Rate Cut After 'Exceptionally Weak' Jobs Report -- Market Talk

5 set 2025, 17:25 UTC

Discorsi di Mercato

Bets on Hefty Fed Cut Seen as Exaggerated -- Market Talk

5 set 2025, 17:20 UTC

Discorsi di Mercato

U.S. Oil Rig Count Rises By 2 to 414 -- Market Talk

5 set 2025, 17:17 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

5 set 2025, 17:17 UTC

Discorsi di Mercato

Bank of Canada Policy Seen Moving to Expansionary Territory -- Market Talk

5 set 2025, 17:03 UTC

Discorsi di Mercato

Bank of Canada Expected to Cut, But Inflationary Pressures Remain a Concern -- Market Talk

5 set 2025, 16:39 UTC

Acquisizioni, Fusioni, Takeovers

Yorkville Acquisition: Commencing at Market Open on Sept 8, Common Stk Will Trade on Nasdaq Under New Ticker Symbol 'MCGA' >YORK

5 set 2025, 16:39 UTC

Acquisizioni, Fusioni, Takeovers

Yorkville Acquisition: Will Be Renamed to Trump Media Group CRO Strategy Upon Closing of Combination Between Yorkville, Trump Media & Technology Group Corp. and Crypto.com >YORK

5 set 2025, 16:39 UTC

Acquisizioni, Fusioni, Takeovers

Yorkville Acquisition Corp.: Announces Ticker Symbol Change to 'MCGA' Ahead of Trump Media Group CRO Strategy, Inc. Listing

5 set 2025, 16:39 UTC

Acquisizioni, Fusioni, Takeovers

Yorkville Acquisition: Outstanding Publicly Traded Units and Warrants Will Trade on Nasdaq Under New Ticker Symbols 'MCGAU' and 'MCGAW', Respectively >YORK

5 set 2025, 16:37 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Global Equities Roundup: Market Talk

5 set 2025, 16:37 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Global Energy Roundup: Market Talk

5 set 2025, 16:37 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Strathcona Buys Up More MEG Shares In Effort to Scuttle Cenovus Deal -- Market Talk

5 set 2025, 16:20 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

5 set 2025, 16:16 UTC

Utili

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Guidewire, and More -- Barrons.com

5 set 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

BioArctic AB Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.